Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice results of a multicentric, retrospective study /
Clinical trials revealed significant antitumor activity for immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC). Due to their strict eligibility criteria, clinical trials include selected patient cohorts, and thus do not necessarily represent real-world population outcomes. I...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | SCIENTIFIC REPORTS
13 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1038/s41598-023-44103-9 |
| mtmt: | 34199654 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/28568 |